...mRNA vaccine combined with Merck’s immunotherapy Keytruda succeeded in a...

[Onion BlueskyOnion Bluesky is verified member.]

Moderna’s mRNA vaccine combined with Merck’s immunotherapy Keytruda succeeded in a late-stage trial for skin cancer, the companies said, sending shares of the vaccine maker up 60% in premarket ​trading. https://cnn.it/4qqzOQ0

View on Bluesky
Source: at://did:plc:kkf4naxqmweop7dv4l2iqqf5/app.bsky.feed.generator/news-2-0
Author: CNN (@cnn.com)